MEDIAN TECHNOLOGIES (EPA:ALMDT) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
MEDIAN TECHNOLOGIES

PRESS RELEASE

published on 07/09/2025 at 17:45, 6 months 29 days ago

Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
Median Technologies reports half-year liquidity contract details with TP ICAP. 60,808 shares and €58,893.66 cash as of June 30, 2025. 469 buy and 395 sell transactions in the first half of 2025

Liquidity Contract Transactions Shares TP ICAP Median Technologies
BRIEF

published on 05/16/2025 at 17:50, 8 months 22 days ago

Median Technologies Announces Voting Rights and Share Capital Details

Share Capital Voting Rights Treasury Shares AMF Regulations Median Technologies
PRESS RELEASE

published on 05/16/2025 at 17:45, 8 months 22 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Median Technologies discloses total voting rights and shares as of April 30, 2025, in compliance with regulations. The French company utilizes AI for cancer diagnosis and treatment

Voting Rights Shares AI Median Technologies Cancer Diagnosis
BRIEF

published on 03/14/2025 at 17:50, 10 months 24 days ago

Median Technologies Maintains its Eligibility for the PEA-PME Scheme

PEA-PME Euronext Growth Tax Benefits Eligibility Median Technologies
BRIEF

published on 02/24/2025 at 17:50, 11 months 11 days ago

Median Technologies: Presentation of eyonis™ LCS at ECR 2025

Artificial Intelligence Median Technologies Lung Cancer Eyonis™ LCS ECR 2025
BRIEF

published on 01/31/2025 at 08:05, 1 year ago

Median Technologies unveils its 2024 financial results and its 2025 outlook

Financial Results FDA Approval Median Technologies Eyonis™ LCS Expansion 2025
PRESS RELEASE

published on 01/31/2025 at 08:00, 1 year ago

Inside Information / Other news releases
Median Technologies reports 2024 financial indicators and 2025 outlook, including eyonis™ LCS FDA clearance and iCRO revenue growth. Strategic milestones and new financing agreements drive towards 2025 goals

Financial Indicators Median Technologies Eyonis LCS 2025 Outlook ICRO Revenue Growth
BRIEF

published on 01/24/2025 at 08:05, 1 year ago

Median Technologies Secures Up to €47.5 Million for AI Lung Cancer Diagnostics

European Investment Bank Median Technologies AI Lung Cancer Diagnostics Eyonis™ EU And US Commercialization
PRESS RELEASE

published on 01/24/2025 at 08:00, 1 year ago

Inside Information / Other news releases
Median Technologies secures up to €47.5 million for eyonis™ AI lung cancer diagnostic regulatory filings & U.S./EU commercialization. New financing & operational enhancements drive profitability & extend cash runway into Q4, 2025

AI Commercialization Median Technologies Lung Cancer Diagnostic Eyonis
BRIEF

published on 11/26/2024 at 17:50, 1 year 2 months ago

Median Technologies Showcases AI Lung Cancer Diagnostic at RSNA 2024

Clinical Trials Eyonis™ LCS RSNA 2024 AI-powered Diagnostics Lung Cancer Screening

Accesswire

Published on 02/07/2026 at 01:00, 1 day 5 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 7 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 8 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 15 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 17 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 9 hours 40 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 14 hours 5 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 14 hours 20 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 11 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 12 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 12 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 14 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 11 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 12 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 12 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE